Is zonulin a regulator of intestinal tight junctions and are higher zonulin levels associated with increased intestinal permeability?

Based on a comprehensive synthesis of clinical, mechanistic, and biomarker-focused research, the physiological role of zonulin is well-established, though its clinical measurement as a proxy for intestinal permeability has notable limitations.

Mechanistic pathways of tight junction regulation

• The PAR-2–EGFR Signaling Axis: Zonulin (prehaptoglobin-2) functions as a primary endogenous modulator of intercellular tight junctions (TJs). Upon secretion, zonulin binds to a cell-surface receptor complex on the apical membrane of intestinal epithelial cells, initiating downstream signaling through proteinase-activated receptor 2 (PAR-2).
• Cytoskeletal Remodeling: Activation of PAR-2 triggers transactivation of the epidermal growth factor receptor (EGFR). This signaling cascade recruits phospholipase C (PLC) and protein kinase C (PKC), which drive downstream mitogen-activated protein kinase (MAPK) pathways.
• Disassembly of Tight Junction Proteins: The activation of these kinases induces polymerization and contraction of the perijunctional actomyosin ring. This mechanical tension leads to the phosphorylation and subsequent redistribution of critical tight junction proteins—specifically zonula occludens-1 (ZO-1), occludin, and claudins. This dynamic, reversible remodeling relaxes cell-to-cell contacts and opens the paracellular pathway.

Clinical and biomarker considerations

• Discrepancy with Functional Tests: Mechanistically, elevated zonulin should lead to increased paracellular flux. However, clinical studies directly comparing commercial serum or fecal zonulin levels with gold-standard functional permeability tests—such as the lactulose-to-mannitol (L:M) or lactulose-to-rhamnose (L:R) differential sugar absorption assays—show weak or absent statistical correlations.
• Assay Specificity Limitations: In clinical evaluations of healthy and diseased cohorts, standard ELISA kits often demonstrate poor target specificity. Evidence shows these assays cross-react with other haptoglobins and zonulin-related proteins rather than exclusively measuring true pre-haptoglobin-2. Consequently, while cohort-level trends often show elevated zonulin in inflammatory or metabolic conditions, individual values do not reliably predict functional barrier integrity.

Bottom line

Zonulin is a scientifically proven physiological regulator of intestinal tight junctions that acts via PAR-2 and EGFR to temporarily open paracellular pathways. However, due to significant cross-reactivity and specificity limitations in commercial ELISA assays, higher measured zonulin levels are only a plausible indicator of increased intestinal permeability, and they do not reliably correlate with functional clinical tests at the individual level.